Klick Health

Overview

Klick Health is the world’s largest independent life sciences marketing and commercialization agency, headquartered in Toronto, Canada. Founded in 1997 by Leerom Segal and Aaron Goldstein, the agency has grown to $660M in revenue (2024) with 1,466 employees, achieving an extraordinary revenue-per-employee ratio of $450K+ — roughly double the $200-300K industry norm for health agencies. This efficiency is driven by a single-P&L operating model (no siloed business units), proprietary AI tools that augment human work, and a culture of founder-led operational discipline.

In November 2025, Linden Capital Partners and GIC (Singapore’s sovereign wealth fund) made a growth investment valuing Klick at approximately $2.5 billion (3.8x revenue, ~18x estimated EBITDA), replacing previous minority investor GTCR. Critically, founders retain control — this is a minority investment, not a buyout, preserving the culture and operating model that drives Klick’s outperformance.

Klick serves 16 of the top 20 pharmaceutical companies and has won 141+ creative awards in 2024 alone, including Clio Independent Agency of the Year (3x winner) and One Show Agency of the Year — the first health agency to receive that honor.

Services & Capabilities

Core Agency Services

• Brand strategy and launch readiness
• Creative development (141+ awards in 2024)
• Medical communications and scientific content
• Digital and omnichannel marketing (HCP, patient, payer)
• Media planning, buying, and programmatic execution
• Disease awareness campaigns
• CRM strategy and implementation
• Clinical review and analysis
• Regulatory and legal review support (MLR)
• Film/video production
• Experience design and UX

Peregrine Market Access (acquired January 2025)

• Market access strategy and consulting
• Payer engagement and value communication
• HEOR and outcomes-based strategy
• Pricing and reimbursement advisory

Klick Labs (Research Division)

• Vocal biomarker research: Using voice analysis and AI to detect disease signatures
• Published research on detecting Type 2 diabetes, Parkinson’s, and other conditions from voice samples
• Bridge between agency work and health tech innovation

btwelve (Venture Studio)

• Internal venture studio incubating health technology startups
• Leverages Klick’s AI, design, and domain expertise to build new health products

Competitive Position

Klick occupies a unique position: the scale of a network agency with the independence and agility of a founder-led firm, augmented by proprietary AI tools that no competitor has replicated.

Key competitors:

• Independent health agencies: Indegene, Real Chemistry, Area 23 (IPG Health), FCB Health
• Network agencies: Publicis Health, IPG Health, Havas Health, Ogilvy Health
• Technology/AI-enabled: Indegene (Cortex), Accenture Song (Life Sciences)

Strengths:

• $450K+ revenue per employee (2x industry norm) demonstrates genuine AI/efficiency advantage
• Single-P&L model eliminates internal competition and enables cross-functional collaboration
• Founder control preserved through minority PE structure — protects culture
• 16 of top 20 pharma clients; deep, sticky relationships
• 141+ awards in 2024; Clio Independent Agency of Year (3x), One Show Agency of Year (historic first for a health agency)
• Proprietary AI tool suite is years ahead of competitors

Weaknesses:

• Geographic concentration: Toronto HQ with limited global presence (Ward6 Singapore acquisition in March 2025 is early)
• $2.5B valuation on $660M revenue (3.8x) is premium — needs continued growth to justify
• Founder dependency: Leerom Segal and Aaron Goldstein are central to culture and strategy
• Guardrail and other AI tools need productization/external licensing to prove standalone value

14% CAGR (2022-2024) is strong for an agency but moderate compared to tech-enabled competitors like Indegene (28% 10-year CAGR).

Recent Developments

• November 2025 (announced July 2025): Linden Capital Partners and GIC (Singapore sovereign wealth fund) growth investment at ~$2.5B valuation, replacing GTCR as minority investors. Founders retain control.
• January 2025: Acquired Peregrine Market Access, adding market access strategy, HEOR, and payer engagement capabilities.
• March 2025: Acquired Ward6’s Singapore operations, establishing first APAC presence.
• 2024-2025: Launched multiple AI products:
  • HCP AI FocusGroup (simulated HCP reactions to marketing materials)
  • InsightFull (HITL AI engine for market insights)
  • Site AiQ (clinical trial site intelligence)
  • Guardrail (AI-powered compliance and MLR review)
  • KCM+AI (AI social media moderator)
  • LOVENet (drug repurposing AI)
• December 2024: Added 22 senior leaders; September 2025: Added 21 more senior hires.
• 2024: Won 141+ creative awards including Clio Independent Agency of the Year (3rd time) and One Show Agency of the Year (first health agency ever).

Client & Partner Ecosystem

• Penetration: 16 of top 20 pharmaceutical companies
• Named clients (from public disclosures): Bayer, Biohaven, Amgen, Eli Lilly, GlaxoSmithKline, Pfizer, Bristol Myers Squibb, Novartis
• Partners: Komodo Health (data partnership)
• Venture relationships: btwelve venture studio creates health tech startups that may serve or partner with pharma clients

Technology Platform

Klick’s proprietary AI tool suite is a key differentiator, developed in-house and deployed across client engagements:

Tool	Function	Status
HCP AI FocusGroup	Simulates HCP reactions to marketing materials using AI personas	Deployed
InsightFull	Human-in-the-loop AI engine for generating market insights from unstructured data	Deployed
Site AiQ	AI-powered clinical trial site intelligence and selection	Deployed
Guardrail	AI compliance tool for medical-legal-regulatory (MLR) review	Deployed; key productization test
KCM+AI	AI social media content moderator for pharma compliance	Deployed
LOVENet	Drug repurposing AI identifying novel therapeutic applications	Research stage
Klick Labs vocal biomarkers	Voice-based disease detection (diabetes, Parkinson’s)	Research/published

Guardrail is the key productization test: If Klick can license Guardrail as a standalone SaaS product to pharma companies (beyond its own client engagements), it could shift the business model from pure agency (people-based) to hybrid agency+product (recurring SaaS revenue). This is the single most important strategic initiative to watch.

Therapeutic Focus

Broad coverage across all major therapeutic areas with notable depth in:

• Oncology
• Rare disease
• Immunology
• Neurology
• Metabolic disease
• Cardiovascular
• Mental health
• Women’s and men’s health

ZoomInfo](https://www.zoominfo.com/c/klick-health/37997841)

• MM+M Agency 100 2024/2025
• BusinessWire Investment News
• D&B
• Consulting Page
• raw/research/klick-health.pplx.md